Approval of Cubist's newest skin infection drug expected by day's end
June 20, 2014 at 14:41 PM EDT
The U.S. Food and Drug Administration is widely expected to approve a new drug by Cubist Pharmaceuticals to fight skin infections such as MRSA before the end of the day...
